» Articles » PMID: 37755636

Causal Association Between Tea Consumption and Gout: A Mendelian Randomization Study

Overview
Journal Curr Med Sci
Specialty General Medicine
Date 2023 Sep 27
PMID 37755636
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Evidence from prospective studies on the consumption of tea and risk of gout is conflicting and limited. We aimed to investigate the potential causal effects of tea intake on gout using Mendelian randomization (MR).

Methods: Genome-wide association studies in UK Biobank included 349 376 individuals and successfully discovered single-nucleotide polymorphisms linked to consumption of one cup of tea per day. Summary statistics from the Chronic Kidney Disease Genetics consortium included 13 179 cases and 750 634 controls for gout. Two-sample MR analyses were used to evaluate the relationship between tea consumption and gout risk. The inverse-variance weighted (IVW) method was used for primary analysis, and sensitivity analyses were also conducted to validate the potential causal effect.

Results: In this study, the genetically predicted increase in tea consumption per cup was associated with a lower risk of gout in the IVW method (OR: 0.90; 95% CI: 0.82-0.98). Similar results were found in weighted median methods (OR: 0.88; 95% CI: 0.78-1.00), while no significant associations were found in MR-Egger (OR: 0.89; 95% CI: 0.71-1.11), weighted mode (OR: 0.80; 95% CI: 0.65-0.99), and simple mode (OR: 1.01; 95% CI: 0.75-1.36). In addition, no evidence of pleiotropy was detected by MR-Egger regression (P=0.95) or MR-PRESSO analysis (P=0.07).

Conclusion: This study provides evidence for the daily consumption of an extra cup of tea to reduce the risk of gout.

References
1.
Li Q, Li X, Wang J, Liu H, Kwong J, Chen H . Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements. BMJ Open. 2019; 9(8):e026677. PMC: 6720466. DOI: 10.1136/bmjopen-2018-026677. View

2.
Singh J, Gaffo A . Gout epidemiology and comorbidities. Semin Arthritis Rheum. 2020; 50(3S):S11-S16. DOI: 10.1016/j.semarthrit.2020.04.008. View

3.
Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P . EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006; 65(10):1312-24. PMC: 1798308. DOI: 10.1136/ard.2006.055269. View

4.
Bai L, Zhou J, Zhou T, Newson R, Cardoso M . Incident gout and weight change patterns: a retrospective cohort study of US adults. Arthritis Res Ther. 2021; 23(1):69. PMC: 7923519. DOI: 10.1186/s13075-021-02461-7. View

5.
Rho Y, Lu N, Peloquin C, Man A, Zhu Y, Zhang Y . Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study. Ann Rheum Dis. 2014; 75(1):91-5. PMC: 4388809. DOI: 10.1136/annrheumdis-2014-205827. View